UltraSPARC-III (US-III) is a 64b 800MHz 4-instruction-issue superscalar microprocessor for high-performance desktop workstation, work group server, and enterprise server platforms. On-chip caches include a 64kB 4-way associative for data (D$), 32kB 4-way associative for instructions (I$), a 2kB 4-way associative data prefetch cache (P$), and a 2kB 4-way associative write (W$). A 90kB on-chip tag array supports the off-chip 8MB unified second-level cache (E$) [1]. The 23M-transistor chip in a 0.15µm, 7-layer metal process consumes 60W from a 1.5V supply [2].The architecture is driven by performance, scalability and compatibility. The design is SPARC V9-compliant, maintaining binary compatibility with all 10,000+ existing SPARC applications [3]. Scalability in two directions is required: 1) taking full entitlement of future process improvements to scale clock rate and 2) off-chip interfaces that enable scaling multi-processor (MP) systems to 1000+ processors. Performance can be achieved in multiple ways. Clock rate is prioritized over IPC improvements, setting a goal of 1.5x the clock rate compared to the previous designs in the same process technology, as well as IPC and compiler improvement goals of 1.15x each, for a doubling of overall performance[4]. This requires different approaches to the micro-architecture, as well as more aggressive circuit and physical design, compared to previous UltraSPARC processors [5,6]. 8 static gates are budgeted for each of the 14 pipeline stages vs. 9 stages and 20 static gates/stage on US-I/II. Timing is more critical in the instruction fetch, integer execution, and floating-point (FP) areas, where dynamic logic is used liberally, than in the memory system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.